Fall35% Off Sitewide

Code…

For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.

TB-500 — studio product photo

Cellular Peptide

TB-500

Thymosin Beta-4Tβ4TB4Thymosin β4

A 43-amino-acid fragment of thymosin beta-4 studied in preclinical models for actin regulation and cell migration during tissue repair.

Quantity

1

$39.99

Bundle & save

What's the reconstitution solution? →

Order by 3:00 PM ET for same-day dispatch

Cutoff 3:00 PM ET · same-day dispatch

Estimated arrival in 2 business days

Overnight shipping available

Free shipment protection included

Free shipping over $150 Secure 256-bit SSL checkout

TB-500

1 × 10mg · $39.99

99% purity, QC passed

HPLC + mass-spec verified

Shipment protection

Free on every order

Free shipping over $150

Same-day dispatch before 3PM ET

About TB-500

Structure and research context

TB-500 as catalogued here corresponds to thymosin beta-4 (Tβ4), a 43-residue polypeptide of about 4,963 Da (CAS 77591-33-4). Tβ4 is the most abundant member of the beta-thymosin family in mammalian tissue and is regarded as the main G-actin sequestering peptide, binding actin monomers and holding them out of filaments. A seven-residue actin-binding motif, LKKTETQ (residues 17 to 23), has been mapped within the sequence, and the N-terminal tetrapeptide Ac-SDKP is released from Tβ4 by the enzymes meprin α and prolyl oligopeptidase.

TB-500 in the research literature

Tβ4 has been studied mainly in cell-culture and rodent systems focused on cell migration and vascular signaling. It promoted migration of umbilical vein endothelial cells, and the isolated actin-binding motif reproduced its endothelial migration and aortic-ring sprouting activity at about 50 nM. It also stimulated keratinocyte migration in vitro, and in a rat full-thickness dermal excision model it was associated with increased reepithelialization, collagen deposition and angiogenesis.

In cardiomyocyte cultures Tβ4 formed a complex with PINCH and integrin-linked kinase (ILK), leading to activation of Akt, and after coronary artery ligation in mice it was associated with upregulated ILK and Akt activity.

Summarized from peer-reviewed literature for research context only; not a product claim. PubMed: 14500546 · 10469335 · 30854877 · 23084823 · 15565145

TB-500 Certificate of Analysis

Third-party tested · Independent analytical lab

10 recent lots on file

10mg

99.12%latest

TestedMeasuredPurity
Jul 2026Sterile11.77mg99.12%
Jun 202611.62mg98.81%
Jun 202611.64mg98.60%
May 202611.80mg99.02%
Apr 202611.99mg99.77%
Apr 202611.75mg99.89%
Mar 202611.87mg99.82%
Mar 202611.39mg99.81%
Feb 202611.35mg99.61%
Dec 202511.87mg99.87%

Latest safety testing

Sterility
TAMC/TYMCJul 2026

Endotoxin, sterility, and heavy-metals reports are run on individual lots on a rotating basis, separate from the identity/purity assay above — not on every lot.

Frequently researched together

Commonly studied alongside TB-500.

Compound information

Technical specifications

Molecular profile

TypeEndogenous peptide/synthetic analog
CAS number77591-33-4
Molecular weight4,963 Da
Amino acids43

Storage & stability

Lyophilized: -20°CReconstituted: 2–8°CProtect from light
  • ❄️

    Lyophilized (powder)

    -20°C · stable 2+ years

  • ❄️

    Reconstituted

    2–8°C · use within 30 days

TB-500 sources & references

Peer-reviewed literature, for research context

More in Tissue Repair

Every Tissue Repair research compound in the catalog.

Important research notice

Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.

Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.

By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.